X0202 SCHEDULE 13G/A 0001140361-24-008099 0001858703 XXXXXXXX LIVE 2 Common shares, no par value 03/31/2026 0001808158 Repare Therapeutics Inc. 760273102 7171 Frederick Banting, Building 2 Suite 270 Saint-Laurent A8 H4S 1Z9 Rule 13d-1(b) Blue Owl Capital Holdings LP DE 0.00 0.00 0.00 0.00 0.00 0.00 PN Repare Therapeutics Inc. 7171 Frederick Banting, Building 2, Suite 270, Saint-Laurent, Quebec, Canada H4S 1Z9 This statement is filed by Blue Owl Capital Holdings LP. 399 Park Avenue, New York, New York 10022 See response to row 4 on the cover page. N IA See response to row 9 on the cover page. See response to row 11 on the cover page. See response to row 5 on the cover page. See response to row 6 on the cover page. See response to row 7 on the cover page. See response to row 8 on the cover page. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Blue Owl Capital Holdings LP /s/ Karen Hager 05/13/2026